Researchers conducted a multicenter retrospective study involving 92 patients with methotrexate‑induced osteopathy to characterize the affected population, describe fracture patterns, and identify ...

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of heart disease in people ...

Disease-modifying drug therapies are being sought intensively for osteoarthritis (OA), but none have proved out thus far. A previous trial in patients with OA of the hand had found that methotrexate ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. The steps clinicians and people who are at ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International ...

Researchers develop targeted polymersomes to enhance methotrexate delivery, offering a promising new approach for treating aggressive choriocarcinoma. Study: ENT-1-Targeted Polymersomes to Enhance the ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Delaying methotrexate initiation for 1 month after pneumococcal vaccination improves humoral ...

Methotrexate is a generic drug prescribed to treat certain types of cancers, arthritis, and psoriasis in adults and some children. As with other drugs, methotrexate can cause side effects, such as ...

Credit: Shorla Oncology. Jylamvo contains 2mg of methotrexate per mL and is packaged in bottles containing 60mL of oral solution. Jylamvo, a Food and Drug Administration (FDA)-approved oral solution ...

Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...